Opus Genetics (IRD) Depreciation & Amortization (CF) (2010 - 2026)
Opus Genetics' (IRD) quarterly Depreciation & Amortization (CF) came in at $13000.0 in Q1 2026, little changed year-on-year from $13000.0 in Q1 2025, and little changed on a QoQ basis from $13000.0 in Q4 2025.
Opus Genetics (IRD) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends
Opus Genetics (IRD) has 17 years of Depreciation & Amortization (CF) data on file, last reported at $13000.0 in Q1 2026.
- On a quarterly basis, Depreciation & Amortization (CF) changed 0.0% year-over-year to $13000.0 in Q1 2026; TTM through Mar 2026 was $53000.0, a 130.43% increase from a year earlier, with the FY2025 full-year figure at $53000.0, up 430.0% from the prior year.
- Depreciation & Amortization (CF) for Q1 2026 stood at $13000.0, roughly flat from $13000.0 in the prior quarter.
- Over the last five years, Depreciation & Amortization (CF) for IRD reached as high as $14000.0 in Q2 2025 and fell as low as $1000.0 in Q1 2022.
- Historically, Depreciation & Amortization (CF) has averaged $6142.9 across 5 years, with a median of $2000.0 in 2022.
- Across the five-year window, Depreciation & Amortization (CF) changed 0.0% in 2022 and soared 233.33% in 2024, its largest moves.
- Year by year, Depreciation & Amortization (CF) stood at $1000.0 in 2022, then jumped by 200.0% to $3000.0 in 2023, then surged by 233.33% to $10000.0 in 2024, then gained by 30.0% to $13000.0 in 2025, then changed by 0.0% to $13000.0 in 2026.
- Per Business Quant data, the three most recent Depreciation & Amortization (CF) figures were $13000.0 in Q1 2026, $13000.0 in Q4 2025, and $13000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 41.14 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 91,781.47 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 55.90 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 123.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.20 Mn |
| 10 | Opus Genetics | 3.27 Mn | -56.73 Mn | - | 13,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13,000.00 |
| Mar 31, 2026 | 13,000.00 |
| Dec 31, 2025 | 13,000.00 |
| Dec 31, 2025 | 13,000.00 |
| Sep 30, 2025 | 13,000.00 |
| Sep 30, 2025 | 13,000.00 |
| Jun 30, 2025 | 14,000.00 |
| Jun 30, 2025 | 14,000.00 |
| Mar 31, 2025 | 13,000.00 |
| Mar 31, 2025 | 13,000.00 |
| Dec 31, 2024 | 10,000.00 |
| Dec 31, 2024 | 10,000.00 |
| Dec 31, 2023 | 3,000.00 |
| Dec 31, 2023 | 3,000.00 |
| Sep 30, 2023 | 1,000.00 |
| Sep 30, 2023 | 1,000.00 |
| Jun 30, 2023 | 1,000.00 |
| Jun 30, 2023 | 1,000.00 |
| Mar 31, 2023 | 1,000.00 |
| Mar 31, 2023 | 1,000.00 |